Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000231935 | SCV000290604 | uncertain significance | Fanconi anemia complementation group E | 2022-10-31 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 340 of the FANCE protein (p.Gly340Arg). This variant is present in population databases (rs45524646, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with FANCE-related conditions. ClinVar contains an entry for this variant (Variation ID: 134340). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FANCE protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Illumina Laboratory Services, |
RCV000231935 | SCV000462669 | uncertain significance | Fanconi anemia complementation group E | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Fulgent Genetics, |
RCV000231935 | SCV000895764 | uncertain significance | Fanconi anemia complementation group E | 2022-02-09 | criteria provided, single submitter | clinical testing | |
Institute for Clinical Genetics, |
RCV001194808 | SCV002011427 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001194808 | SCV005327701 | uncertain significance | not provided | 2023-12-24 | criteria provided, single submitter | clinical testing | Reported in a patient with severe aplastic anemia referred for whole exome sequencing (PMID: 35776903); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 24728327, 35776903) |
ITMI | RCV000121014 | SCV000085182 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Leiden Open Variation Database | RCV001194808 | SCV001364605 | uncertain significance | not provided | 2011-02-07 | no assertion criteria provided | curation | Curator: Arleen D. Auerbach. Submitter to LOVD: Arleen D. Auerbach. |